Keyphrases
Toxoplasma Gondii (T. gondii)
100%
MAP Kinase Phosphatase
25%
Apicomplexan
25%
Enoyl Acyl Carrier Protein Reductase
25%
Immune Response
22%
Liposomes
21%
Arginase-1 (Arg-1)
19%
Apicomplexan Parasites
18%
Triclosan
17%
Step Change
17%
Self-amplifying RNA Vaccine
17%
Cellular Uptake
17%
Macrophages
17%
Host Cell
15%
Toxoplasmosis
15%
Cationic Lipids
14%
Cationic Liposomes
13%
Small Activating RNA (saRNA)
12%
Protective Behavior
12%
Dimethyldioctadecylammonium
12%
Inducible Nitric Oxide Synthase
11%
Nonionic Surfactant
11%
Biodistribution
11%
Antibiotics
11%
Toxoplasma Gondii Infection
11%
Reductase Enzymes
10%
Delivery System
10%
Interleukin-6
10%
Tachyzoite
10%
CD8+ T Cells
10%
Virus
10%
Specific Antibodies
10%
Immunogenicity
10%
Trimethylammonium
9%
Propane
9%
Adjuvanted
9%
Monocyte Chemoattractant protein-1 (MCP-1)
9%
Bradyzoite
9%
IC50
9%
C57BL
9%
Hyporesponsiveness
8%
Disease Phenotype
8%
Cationic Lipid Nanoparticles
8%
Healers
8%
Diarylethene
8%
Subunit Vaccine
8%
Benzimidazole
8%
Enzyme Targets
8%
Antigen-specific Antibody
8%
HLA-A
8%
Pharmacology, Toxicology and Pharmaceutical Science
Toxoplasma gondii
43%
Liposome
25%
Oxidoreductase
25%
Infection
22%
Apicomplexan Infection
20%
IC50
20%
Nanoparticle
18%
Triclosan
17%
mRNA Vaccine
17%
Solid Lipid Nanoparticle
17%
Mouse
14%
Biodistribution
14%
Apicomplexa
14%
Vaccine
12%
Antibiotic Agent
12%
Acyl Carrier Protein
11%
Toxoplasmosis
11%
1,2 Dioleoyl 3 Trimethylammoniopropane
9%
Adjuvant
9%
Antibodies
9%
Benzimidazole
8%
Subunit Vaccine
8%
Protein Corona
8%
Zein
8%
Salicylanilide Derivative
8%
Dicetyl Phosphate
8%
Glycerophosphate
8%
Melioidosis
8%
Route of Administration
8%
Immunogenicity
8%
Melanoma
8%
Anura
8%
Malignant Neoplasm
8%
Biological Activity
8%
Microbiome
8%
Micelle
8%
Drug Development
8%
RNA Vaccine
7%
Levofloxacin
6%
Infectious Agent
6%
Solid Lipid Nanoparticle
6%
Coenzyme Q - Cytochrome C Reductase
5%
Drug Delivery System
5%
Tachyzoite
5%
Bradyzoite
5%
Lead Compound
5%
Plasmodium falciparum
5%
Cytochrome B
5%
Dimethyldioctadecylammonium Bromide
5%
Vaccine Adjuvant
5%
Immunology and Microbiology
Toxoplasma gondii
55%
Mouse
50%
Vaccine Efficacy
32%
Macrophage
23%
Immune Response
20%
Host Cell
15%
Toxoplasmosis
14%
Transgenic Mouse
11%
Cytotoxic T-Cell
11%
Interleukin-6
10%
TLR4
10%
T Cell
9%
RNA Vaccine
8%
Surface Property
8%
C57BL 6 Mouse
8%
Dendritic Cell
8%
Molecular Model
8%
Mitogen
8%
Oocyst
8%
Interleukin 12
8%
Multi-Omics
8%
Inflammatory Arthritis
8%
Blood Brain Barrier
8%
Immunogenetics
8%
HLA A11 Antigen
8%
Bagg Albino Mouse
8%
Bone Marrow Derived Dendritic Cell
8%
Epitope
8%
Leishmania Major
8%
Acanthamoeba
6%
Neutrophil Granulocyte
6%
Coated Vesicle
6%
Parasite Load
6%
Cell Invasion
6%
Major Histocompatibility Complex
5%
Attenuated Vaccine
5%
Live Vaccine
5%
Peptide Vaccine
5%
Encephalitis
5%
Wild Type
5%
Apicomplexa
5%
Tachyzoite
5%
Wild Type Mouse
5%
Infectious Agent
5%
